New

Create, analyze, optimize your ETF portfolio. Start now →

Advertisement
Advertisement

XHSvsBBPETF Comparison

ETF 1
XHS

State Street SPDR S&P Health Care Services ETF

This fund is part of
US Health Care
-1.08%
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-0.34%

State Street SPDR S&P Health Care Services ETF (XHS) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. XHS is less expensive with a Total Expense Ratio (TER) of 0.35%, versus 0.79% for BBP. XHS is up 1.76% year-to-date (YTD) with +$9M in YTD flows. BBP performs better with 6.67% YTD performance, and +$12M in YTD flows. Run a side-by-side ETF comparison of XHS and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

XHS vs BBP performance and flow charts

Performance

-4.0-2.00.02.04.06.08.0%Mar 23Mar 30Apr 7Apr 14Apr 21

Cumulative Flows

-4 M-2 M0 M2 M4 M6 M8 MMar 23Mar 30Apr 7Apr 14Apr 21

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/24/2026
1M3MYTD1Y3Y5Y
Perf.
XHS
BBP
+7.11%+5.15%
-2.43%+2.18%
+1.76%+6.67%
+14.80%+51.84%
+21.34%+65.27%
-0.83%+58.71%
Flows
XHS
BBP
+$1M+$8M
-$5M+$12M
+$9M+$12M
-$3M+$27M
-$30M+$27M
-$34M+$17M
Volatility and drawdown
3M1Y3Y5Y
Volatility
XHS
BBP
+18.84%+28.39%
+17.87%+24.04%
+18.09%+23.76%
+21.14%+26.19%
Max drawdown
XHS
BBP
-11.77%-9.59%
-12.54%-9.81%
-17.78%-25.54%
-32.53%-38.24%
Max drawdown duration
XHS
BBP
88d48d
128d36d
362d292d
1761d915d
Trading data

Create an account to view trading data

Join for free
XHS
BBP
Last sale
4/24/2026 at 7:59 PM
$108.86
$84.11
Previous close
04/24/2026
$107.79
$86.08
Consolidated volume
04/24/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
XHS
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/24/2026 at 7:59 PM
Live
Closed
XHS
BBP
Last price
$108.86
$84.11
1D performance
+0.99%
-2.30%
AuM$93.51 M$59.56 M
E/R0.35%0.79%
Characteristics
XHS
BBP
Management strategyPassivePassive
ProviderState Street Investment ManagementVIRTUS Investment Partners
BenchmarkS&P Health Care Services Select Industry IndexLifeSci Biotechnology Products Index
N° of holdings5156
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 28, 2011December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

XHS
USA
99.89%
Other
0.11%
BBP
USA
89.45%
Other
10.55%

Sectors

XHS
Health Care
86.56%
Other
13.44%
BBP
Health Care
88.78%
Other
11.22%

Diversification

XHS

Total weight of top 15 holdings out of 15

30.62%
BBP

Total weight of top 15 holdings out of 15

33.42%

Top 15 holdings

Data as of March 31, 2026
XHS
MEDNAX
2.18%
HEALTHEQUITY I/D
2.15%
GUARDANT HEALTH INC
2.12%
CORVEL
2.08%
US10950A1060
2.08%
CIGNA
2.06%
HUMANA
2.05%
ELEVANCE HEALTH INC
2.04%
DAVITA INC
2.00%
US5049221055
1.99%
ACADIA HEALTHCARE COMPANY
1.98%
CARDINAL HEALTH
1.98%
ALIGNMENT HEALTHCARE
1.98%
QUEST DIAGNOSTICS
1.97%
PROGYNY INC
1.96%
BBP
BIOCRYST PHARMACEUTICALS
2.50%
ROIVANT SCIENCES LTD
2.45%
SYNDAX PHARMACEUTICALS INC
2.40%
GILEAD SCIENCES
2.25%
GERON
2.24%
GB00BRXB0C07
2.23%
KALVISTA PHARMACEUTICALS INC
2.22%
AMGEN-T
2.20%
AXSOME THERA CMN STK
2.20%
AGIOS PHARMA/D
2.18%
BIOGEN INC
2.17%
UTD THERAPEUT
2.13%
LIGAND PHARMACEUTICALS
2.13%
BIOMARIN PHARMACEUTICAL
2.06%
EXELIXIS
2.05%
Frequently asked questions about XHS and BBP

How have the XHS and BBP ETFs performed in 2026?

As of April 24, 2026, XHS is up 1.76% year-to-date (YTD), while BBP has returned 6.67%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: XHS or BBP?

Year-to-date, the XHS ETF saw +$9M in flows, compared to +$12M for BBP.

Which ETF is more volatile: XHS or BBP?

Over the past year, XHS had a volatility of 17.87%, while BBP experienced 24.04%.

Which ETF is bigger: XHS or BBP?

As of April 24, 2026, XHS holds $93.51 M in assets under management (AUM), while BBP manages $59.56 M.

What sectors do the XHS and BBP ETFs invest in?

XHS leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the XHS ETF and BBP ETF?

XHS top holdings include MEDNAX, HEALTHEQUITY I/D and GUARDANT HEALTH INC. BBP holds in its top three: BIOCRYST PHARMACEUTICALS, ROIVANT SCIENCES LTD and SYNDAX PHARMACEUTICALS INC.

Which ETF is more diversified: XHS or BBP?

XHS holds 58 securities with 30.62% of its assets in the top 15. BBP has 61 securities and a top 15 weight of 33.42%.

Advertisement
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.